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1. Introduction 
Helicobacter pylori is a spiral, microaerophillic, Gram-negative bacterium. Infection by H. 
pylori has been established as the major cause of chronic gastritis and plays important role in 
the pathogenesis of other gastroduodenal diseases such as peptic ulceration, gastric 
lymphoma, and gastric cancer (Israel and Peek 2001). H. pylori is considered to be the most 
common chronic bacterial infection in humans (Cave 1996). The prevalence has been 
estimated to range from 40 to 80% and it varies widely by geographic area, age, race, 
ethnicity, and socioeconomic status (Bures et al. 2006). In most cases the infection is silent, 
clinical manifestation appears in only 10-15% of infected individuals. This is due to different 
strength of virulence of H. pylori strains and different host immune system response 
(Stromberg et al. 2003). 
The stomach was supposed to be the only reservoir of infection in humans. Nevertheless H. 
pylori infection was detected in other sites recently. It was found in dental plaque and saliva 
(Kim et al. 2000) and also in oropharyngeal lymphatic tissue (Pavlik et al. 2007). This finding 
is of great importance because of known carcinogenic potential of H. pylori. It was declared 
type I carcinogen by IARC (1994). The question of direct contribution of H. pylori to oral and 
oropharyngeal diseases was not resolved yet.  
2. H. pylori pathogenesis 
Immunological changes caused by H. pylori in the stomach mucosa were explained recently 
(Tummala et al. 2004). There are no more detailed data about effect of H. pylori in the oral or 
oropharyngeal mucosa. H. pylori has several mechanisms to elude host defences (Portal-
Celhay and Perez-Perez 2006). It is able to survive the acidic gastric environment by 
producing the enzyme urease, which metabolizes urea to carbon dioxide and ammonia to 
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buffer the gastric acid. H. pylori moves across gastric mucus and can adhere to epithelial 
cells using a variety of adhesin-like proteins (Sachs et al. 2003). Once adhered to epithelial 
cells, H. pylori induces a strong immune system response (Crabtree 1996). This response 
does not lead to elimination of the bacterium, but causes development of chronic 
inflammation. H. pylori is not eradicated unless an infected individual is treated with a 
combination of antibiotics (Portal-Celhay and Perez-Perez 2006). Chemical products of H. 
pylori attract cells of the immune system into lamina propria (Blanchard et al. 2004). It was 
shown that H. pylori can induce the maturation and activation of monocyte-derived 
dendritic cells. This activity is mediated by TLRs (Toll-like receptors) expressed on antigen 
presenting cells and leads to promotion of NK and Th1 effector responses (Portal-Celhay 
and Perez-Perez 2006). IFN – gamma producing Th1 polarized T cells and activated NK cells 
have been suggested to play an important role for development of severe pathologies (Hafsi 
et al. 2004). 
H. pylori infection in gastric mucosa is associated with the production of both 
proinflammatory and immunomodulatory cytokines. Changes in secretion of IL-8, IL-1beta, 
IL-6, TNF-alpha, TGF-beta were described (Stromberg et al. 2003). These cytokines are 
produced by both the immune system and epithelial cells. The response of host cells is 
dependent on production of H. pylori virulence factors (Blanchard et al. 2004). The most 
important virulence factors, which are associated with gastric diseases, are CagA (cytotoxin 
associated gene A) and VacA (vacuolizating cytotoxin A). 
3. H. pylori virulence factors 
Genome sequence analysis led to identification of genes encoding these virulence factors 
grouped in the so-called pathogenicity island (cagPAI). It is a genomic region containing 
about 30 genes including genes for type IV secretion system (Mobley 1996). H. pylori strains 
producing CagA are associated with increased risk of severe gastric pathologies compared 
with CagA negative strains (Portal-Celhay and Perez-Perez 2006). Injection of bacterial 
proteins into the gastric cells by a type IV bacterial secretion system (a multi-molecular 
complex that mediates the translocation of bacterial factors into the host cell) has been 
described (Segal et al. 1999; Oliveira et al. 2006). In this way, CagA protein can get inside the 
host cells and stimulate cell signalling through interaction with several host proteins. This 
interaction leads to increased cytokine and regulatory molecule production (Guillemin et al. 
2002) and could be related to initiation of tumour transformation (Segal 1997; Tummala et al. 
2004; Hatakeyama 2006). 
VacA is another important H. pylori virulence factor. This bacterial toxin with multiple 
activities is inserted into the host cell membrane, inducing cytoplasmic vacuolation (Cover 
and Blaser 1992). This toxin is coded by vacA gene, which is present in all H. pylori strains. 
Only about 50% of strains produce VacA protein. This is due to variability of vacA sequence. 
(Portal-Celhay and Perez-Perez 2006). There are several types of signal region (s1a, s1b, s1c, 
s2) and two types of midregion (m1 or m2). H. pylori strains with different forms of vacA 
differ in association with diseases. Strains with s1 signal sequence allele produce intact 
VacA toxin, s2 strains have low cytotoxic activity. Strains with s1/m1 allele combination 
have highest cytotoxic activity and they are associated with gastric ulceration and gastric 
carcinoma (Miehlke et al. 2000). s1/m2 strains are characterized by medium or low VacA 
production and s2/m2 strains do not produce VacA at all (Van Doorn et al. 1999). s2/m1 
strains was found only sporadically (Letley et al. 1999; Martinez-Gomis et al. 2006). 
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Other virulence factors are e.g. adhesins, which help H. pylori to adhere to mucosal epithelial 
cells (Gisbert and Pajares 2004). Important is BabA protein which binds Lewisb antigen, 
which is present in individuals with 0 blood group. Presence of BabA gene is connected to 
increased prevalence of gastric ulcers and gastric carcinoma in Lewisb positive individuals 
(Blanchard et al. 2004). BabA often coexists with vacA s1 and cagA alleles (Kusters et al. 2006). 
4. H. pylori induced carcinogenesis 
H. pylori is a declared type I carcinogen (IARC, 1994). However, the exact way of 
carcinogenesis is not yet fully understood. There are three supposed ways of H. pylori 
carcinogenic action: 
1. H. pylori could act as direct mutagen. Interaction of intracellular signalling molecules 
and H. pylori CagA may predispose cells to accumulate multiple genetic and epigenetic 
changes that promote multistep carcinogenesis (Hatakeyama 2006).  
2. H. pylori produced VacA can cause immunosuppression by blocking proliferation of T 
cells (Boncristiano et al. 2003),  
3. H. pylori can induce cell proliferation by increasing levels of several cytokines and 
regulatory molecules, which are involved in tumour formation and cell transformation 
(Konturek et al. 1997; Sakaguchi et al. 1999; Keates et al. 2001; Gobert et al. 2002; 
Schiemann et al. 2002; Wang et al. 2002). Current information about regulation 
mechanism of epithelial tissue by cytokines and regulatory molecules focus an interest 
mainly on Epithelial Growth Factor (EGF), Transforming Growth Factor (TGF) and NO 
synthases (NOS) (Gallo et al. 1998; Rubin Grandis et al. 1998; Sakaguchi et al. 1999; 
Gobert et al. 2002; Schiemann et al. 2002). 
5. Methods of H. pylori detection in the oral cavity and pharynx 
Diagnostics of H. pylori is significantly developed in gastroenterology. Attempts of H. pylori 
detection in other sites encountered diverse success rates (Dowsett and Kowolik 2003). 
Routinely used tests can be divided into non-invasive and invasive group. When detecting 
extragastric presence of H. pylori, invasive tests must be used based on the detection of 
bacteria in biopsy specimen. These invasive tests are often used to detect extragastric H. 
pylori presence:  
Histology – Several staining methods are in use. These include e.g. haematoxylin and eosin, 
modified Giemsa, Warthin Starry, Gimenez, and Genta (Rotimi et al., 2000). These staining 
methods achieve high sensitivity and specificity rates (up to 96%) (Hep 2003) in case of 
gastric mucosa specimens, where no other bacterial strains are supposed to be present, but 
provide low specificity in the case of oral specimens, where other bacterial strains are often 
found (Dowsett and Kowolik, 2003). Differentiation of H. pylori from other bacteria can be 
very difficult. 
Rapid Urease Test (RUT) or Campylobacter-like Organism (CLO) test is based on detection 
of urease production by H. pylori. When viable H. pylori bacteria are present, urea is being 
cleaved and the change of pH is visualized by colour indicator (Qureshi et al. 1992). This is 
very useful method when dealing with gastric mucosa specimens, in case of other 
specimens results may show high false-positive rate because of some other urease-
producing species presence, e.g. Streptococcus spp., Haemophilus spp. a Actinomyces spp. 
(Dowsett and Kowolik 2003).  
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Culture is currently accepted gold standard for the diagnosis of gastric H. pylori 
(Makristathis et al., 2004). This method achieve 80-90% sensitivity and 90-100% specificity 
rates (Hep 2003). Culture of H. pylori from the oral cavity or oropharynx showed to by 
highly difficult to perform and has met with limited success (Dowsett and Kowolik, 2003). 
Use of special transport medium, microaerophilic environment, supplemented media for 
culture and three to seven days incubation is mandatory. Overgrowth by other bacterial 
species often appears. Direct inhibition of H. pylori by oral species in vitro has also been 
reported (Ishihara et al., 1997). Transformation of H. pylori into unculturable, coccoid form in 
the unfavourable environment was described (Shahamat et al., 2004). 
Immunohistochemistry – to detect extragastric H. pylori is being used only experimentally. 
Tissue sections are incubated with rabbit polyclonal anti-H. pylori antibodies followed with 
the use of streptavidin-biotin-peroxidase kit and haematoxylin and eosin counterstaining 
(Akbayir et al. 2005).  
Molecular methods – are currently generating most possibilities of detection and also typing 
of H. pylori strains. Various modifications of the polymerase chain reaction (PCR) are in use. 
These methods are used only for experimental purposes in the detection of extragastric H. 
pylori. In experiments on the detection of oral and pharyngeal H. pylori many variations of 
PCR diagnosis has been used with a detection rate ranging between 0-90% (Dowsett and 
Kowolik 2003). The lack of uniformity of laboratory procedures can play a role in the 
reported inconsistencies. The described modification exerted different primers and probes 
for the detection of different DNA segments of H. pylori DNA. Various primers were used 
(for example, urease gene, 16S ribosomal RNA genes and others). Specificity and sensitivity 
of different primers, however, can vary significantly (Song et al., 1999). PCR genotyping 
makes it possible to distinguish different H. pylori strains and their carriage of genes 
encoding virulence factors (Pavlik et al. 2007). The discrepancy of published PCR results 
shows the importance of finding suitable PCR assay. Tissue specimens collection and 
especially immediate immersion into proper transport medium is essential for successful 
test results (Pavlik et al. 2007). It has to be considered that PCR allows the detection of a low 
number of bacteria or nonviable bacteria, which cannot influence progress of diseases.  
6. H. pylori in oropharyngeal lymphatic tissue 
Several studies have explored the presence of H. pylori in tonsillar and adenoid tissue. The 
results of these studies were inconsistent with different detection rates. The discrepancies 
are due to different detection methods used. Some of the methods are believed to be 
unsuitable for detection of extragastric H. pylori (e.g. RUT or CLO test). PCR assay is now 
considered the most appropriate method for detection of pharyngeal H. pylori. However, 
differences in the primers and probes used in published studies do not allow drawing 
specific conclusions. Table 1. shows an overview of published papers focused on the 
detection of H. pylori in tonsillar and adenoid tissue. According to above mentioned data 
PCR assay is considered most valuable detection method for extragastric H. pylori detection. 
In their study Di Bonaventura et al. (2001) used PCR for investigation of tonsillar swabs and 
biopsy specimens with no evidence of H. pylori presence. Cirak et al. (2003), Bulut et al. 
(2006) found H. pylori in tonsillar and adenoid tissue by PCR (16S rRNA gene and glmM 
gene respectively). They found H. pylori strains positive for cagA gene. Bitar et al. (2005) 
investigated adenoid tissue specimens by RUT, histology and nested PCR (ureA gene). They 
found positivity by RUT and histology, but no positivity by nested PCR. In their next study 
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these authors investigated middle ear fluids and adenoid tissue specimens using culture, 
RUT and PCR (ureC and adhesion subunit genes). All middle ear fluids were negative. In 
adenoids they found positivity by RUT, but none by PCR (Bitar et al. 2006). Yilmaz et al. 
(2004) found H. pylori in middle ear effusions and in one adenoid tissue specimen using PCR 
(23S rRNA gene). Yilmaz et al. (2006) found H. pylori in 64% of adenoid and tonsillar 
specimens by PCR (16S rRNA gene). Kusano et al. (2007) showed H. pylori positivity in 126 
(72.9%) tonsillar specimens using PCR (16S rRNA gene). They also demonstrated the 
presence of coccoid forms of H. pylori in tonsillar crypts using immunoelectron microscopy. 
Eyigor et al. (2009) found 5,5% of adenoid and tonsillar specimens positive for H. pylori by 
RUT, but none of them positive by PCR (glmM gene). Vilarinho et al. (2010) found 3 adenoid 
and tonsillar specimens positive by RUT, 2 positive by immunohistochemistry, but none 
positive by fluorescence in situ hybridization or PCR (vacA gene). Abdel-Monem (2011) 
found 16 (53.3%) adenoid and tonsillar specimens positive by RUT and 5 (16.6%) specimens 
positive by PCR (ureC gene). Other studies mentioned in Table 1. used different diagnostic 
methods with different detection rates. 
The relationship between H. pylori infection and gastric tumour pathogenesis has been well 
described. It was supposed that H. pylori could act the same way in progression of 
oropharyngeal tumourigenesis. Some authors tried to identify a correlation between H. 
pylori and cancers of head and neck (Table 2.). Tests which determined serum levels of anti-
H. pylori antibodies in patients with head and neck spinocellular carcinoma (HNSCC) 
brought inconsistent results (Grandis et al. 1997; Aygenc et al. 2001; Rubin et al. 2003; 
Nurgalieva et al. 2005). Okuda et al. (2000) proved the presence of H. pylori in oral swab 
specimens and oral cancer specimens using RT PCR (reverse transcriptase polymerase chain 
reaction) and culture. On the other hand Kanda (2005) found no HNSCC specimen positive 
using PCR, culture and immunohistochemical analysis. Kizilay et al. (2006) did not find H. 
pylori in laryngeal SCC and non-neoplastic specimens using haematoxylin and eosin stain or 
modified Giemsa stain. Akbayir et al. (2005) found H. pylori in specimens collected from 
laryngeal cancers and benign laryngeal disorders by histopathological methods, but not by 
immunohistochemical methods. Only one study performed PCR genotyping of H. pylori 
strains in specimens collected from the oropharynx. Tonsillar tissue specimens were 
collected from patients with chronic tonsillitis, obstructive sleep apnea syndrome (OSAS) 
and tonsillar cancer. The detected H. pylori strains differ from strains found in the stomachs 
of Czech patients with gastric diseases (Pavlik et al. 2007).  
7. Comparison of oral and oropharyngeal genotypes 
It is supposed that H. pylori is spread from person to person by oral-oral or faecal-oral route 
(Brown 2000), this hypothesis has not yet been convincingly demonstrated. Assuming the 
oral cavity and oropharynx as a gateway of infection, we can assume that in the oral cavity 
and oropharynx of the same individual we can find H. pylori strains of the same genotype. 
Initial works focused on comparison of oral and gastric H. pylori strains used endonuklease 
restriction analysis, single strand conformation polymorphism analysis (SSCP) or PCR 
(Shames et al. 1989; Khandaker et al. 1993; Zhang and Lu 1997; Kim et al. 2003). Identical 
strains have been found in gastric mucosa and oral cavity. The first comparison of gastric 
and oral H. pylori strains using PCR genotyping performed Wang et al. (2002) and, 
consequently, Burgers et al. (2008). Different genotypes in the stomach and oral cavity were 
found in both studies. PCR assays used by these authors could be considered more accurate 
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Author Year Subjects Specimens Diagnostic Method Number of Subjects positive for H.pylori
Di Bonaventura 2000 36 tonsillar swabs culture, imunohistochemistry 0 (0%)
Di Bonaventura 2001 75 tonsillar swabs and biopsy PCR 0 (0%)
Unver et al. 2001 19 adenoid tissue CLO test 11 (58%)
Skinner et al. 2001 50 tonsillar tissue CLO test, imunocytochemistry 0 (0%) CLO test and imunocytochem.
Uygur-Bayramicli 2002 27 tonsillar tissue histology, imunohistochemistry 0 (0%) histology and imunohistochemistry
Cirak 2003 23 tonsillar and adenoid tissue PCR (16S ribosomal RNA, CagA) 7 ( 30%) positive for H. pylori                         
5 of them (71%) positive for Cag A gene
Yilmaz et al. 2004 50 tonsillar and adenoid tissue CLO test 0 (0%)
Yilmaz et al. 2005 38 adenoid tissue, PCR (23S ribosomal RNA) 12 (67%) in middle ear effusion.                 
middle ear effusions 1 (5%) in adenoid tissue
Pitkaranta 2005 20 adenoid tissue and middle ear fluid culture 0 (0%)
Khademi et al. 2005 56 tonsillar and adenoid tissue CLO test 27 (48%)
Bitar 2005 25 adenoid tissue RUT, histology and nested PCR 21 (84%) positive by RUT,                              
(UreA) 4 (16%) positive by histology  
0 (0%) positive by nested PCR
Bulut 2006 71 tonsillar and adenoid tissue PCR (CagA - glmM gene) 29 (24,6%) postitive for H. pylori                   
17 of them (58,6%) CagA positive
Bitar 2006 28 adenoid tissue and middle ear culture, RUT, PCR (urease-C, 0 (0%) middle ear fluids                                  
fluid adhesion subunit genes) 10 (77%) adenoid tissue by RUT 
0 (0%) by PCR
Yilmaz et al. 2006 22 middle ear fluid, promontorium culture, PCR (16S RNA) middle ear fluids: 2 positive by culture,          
mucosa,adenoid and tonsillar 7 by PCR   
tissue mucosa: 1 by culture, 7 by PCR     
adenoids 11 (50%) by culture,      
14 (64%) by PCR     
tonsillar tissue:12 (55%) by culture,      
14 (64% by PCR)
Kusano et al. 2007 173 palatal tonsils immunohistochemistry,           126 (72,9%) positive
immunoelectron microscopy,  
in-situ hybridization, 
PCR (16S RNA gene)
Vayisoglu et al. 2008 91 tonsillar and adenoid tissue RUT, immunohistochemistry 2 (2,2%) adenoid tissue, 
0 (0%) tonsillar tissue using RUT,           
0(0%) immunohostochemistry
Eyigor et al. 2009 55 35 adenoids, 20 tonsils RUT, PCR (glmM gene) RUT 5,5% positive,
0% PCR positive
Ozcan 2009 25 adenoid tissue, middle ear fluid CLO, immunohistochemistry 0 (0%) CLO positive,                                       
0 (0%) immunohistochemistry positive
Jabbari Moghaddam 2009 285 tonsillar tissue RUT, histopathology 113 (39.6%) positive by histopatology          
40 (14%) positive by RUT
Vilarinho et al. 2010 62 adenoid and tonsillar tissue RUT, immunohistochemistry, 3 positive by RUT,                                            
fluorescence in situ hybridization 2 positive by immunohistochemistry,      
(FISH), PCR-DNA hybridization 0 positive by FISH,  
assay (vacA gene) 0 positive by PCR
Abdel-Monem 2011 20 adenoid and tonsillar tissue RUT, PCR (ureC gene) 16 (53.3%) positive by RUT,                           
5 (16.6%) positive by PCR  
Table 1. Studies focused on detection of pharyngeal presence of H. pylori 
 
Author Year Subjects Specimens Diagnostic Method Number of Subjects Positive for H. pylori
Grandis et al. 1997 42 21 SCC                                   serology - IgG antibodies 57% with SCC                                               
21 controls without SCC 62% controls
Okuda et al. 2000 116 116 gastric and oral samples RT-PCR, culture 46,6% gastric samples                                       
including 58 oral cancers 12,1% oral swab samples   
100% oral cancer swabs
Aygenc et al. 2001 58 26 laryngeal SCC                      serology - IgG antibodies 73% with SCC                                             
32 controls without SCC 41% controls
Rubin et al. 2003 61 6 severe laryngeal dysplasia,        serology 38 seropositive ( including all tonsillar SCC)
5 tonsillar SCC, 50 other SCC
Akbayir et al 2005 100 50 laryngeal SCC                     histopathological and 0 (0%) imunihist.
50 benign laryngeal disorders imunohistochemical methods 28 SCC, 1 benign by histol.
Kanda et al. 2005 31 31 SCC                       PCR, culture, immunohistochemical 21 seropositive
analysis, serology - from urine 0 PCR, culture , immunohist.
Nurgalieva et al. 2005 230 119 laryngeal or pharyngeal SCC  serology - IgG antibodies 32,8% with SCC                                            
111 controls without SCC 27,0% controls
Kizilay et al. 2006 99 69 laryngeal SCC                        histology - HE, modified Giemsa stain 0%
30 nonneoplastic controls
Pavlik et al. 2006 7 3 chronic tonsillitis                       serology IgA, IgG, IgM                         2 of 3 chronic tonsillitis serolgicaly                       
3 tonsillar SCC   PCR genotyping 2 of 3 chronic tonsillitis, 3 of 3 SCC and 1 of 1 
1 OSAS OSAS by PCR  
Table 2. Studies focused on possible role of H. pylori in head and neck carcinogenesis 
(Schabereiter-Gurtner et al. 2004). Findings of Lukes et al. (2009) are in concordance with 
these results. In four of six individuals different genotypes of H. pylori strains were found in 
the stomach and oropharynx. The results also show that from 20 individuals with proven 
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oropharyngeal H. pylori infection, only 8 had concurrent gastric infection. This confirms the 
findings of Burgers et al. (2008), who report that only 38% of persons with demonstrated 
presence of H. pylori in the oral cavity also had the infection in the stomach. These authors 
also reported the finding of 10 cases with positive H. pylori in saliva, with no detectable 
specific anti-H. pylori antibodies in serum. This is consistent with the results obtained by 
Lukes et. al. (2009). H. pylori was found in the oropharynx in 12 patients with no 
demonstrable antibody response. 
8. Conclusions  
Oral cavity (saliva and dental plaque) is now considered a possible extragastric reservoir of 
H. pylori. The published works dealing with oropharyngeal and nasopharyngeal detection of 
H. pylori infection have yielded contradictory results. Pharyngeal detection of H. pylori was 
reported in the range of 0-90%. Regarding that the various authors used different methods 
of detection, it is not possible to reach valuable conclusions. Frequently used tests like CLO 
test and RUT appears to be inappropriate methods for diagnosis of pharyngeal H. pylori. The 
presence of other urease-producing bacterial strains in the pharynx can lead to false positive 
results. Culture has proved to be very difficult and not very resistant to external influences, 
which may even prevent a successful detection. Molecular diagnostics (PCR) can be 
regarded as a method with sufficient sensitivity and specificity. Results achieved by these 
methods demonstrated the presence of H. pylori in the lymphoid tissue of oropharynx and 
nasopharynx. PCR method allows not only detect the presence of H. pylori infection, but also 
genotyping of strains within the tissue. The fact remains that the PCR methods allow 
determine the presence of bacterial DNA but can not determine whether the DNA comes 
from live or dead bacteria. Results of culture despite the very low numbers of positive 
results indicate the possible presence of viable bacteria capable of reproduction. High 
susceptibility of H. pylori in adverse effects during transport of specimens or during 
handling in the laboratory can explain low numbers of positive results of culture. Also, a 
frequent colonisation of oropharyngeal tissue by other bacterial species can have a 
significant influence on the failure of the culture of H. pylori.  
The assumption that the oropharyngeal H. pylori infection may contribute to oropharyngeal 
carcinogenesis as a direct mutagen was not confirmed yet. An analogous situation, however, 
occurs in the stomach, where prevalence of H. pylori infection among the population is 
reported between 40-80%, serious stomach problems such as gastroduodenal ulcer disease 
or gastric cancer has only 10 -15% of infected.  
Virulence of H. pylori strains varies according to the production of toxins. This production is 
due to the presence of virulence factor genes. Most important are the cagA gene and vacA 
gene. The main carcinogenic effect of H. pylori is declared to be associated with the presence 
of cagA gene and s1/m1 combination of alleles of vacA gene. Recent studies indicate that H. 
pylori may exist in the oropharynx independently to the gastric infection. Comparison of 
genotypes of H. pylori in the oral cavity, oropharynx, and stomach showed that an 
individual can host more than one strain of H. pylori in various locations. Differences were 
found in the presence of cagA gene and in the structure of vacA gene. 
The findings of H. pylori in the oral cavity and oropharynx without demonstrable specific 
anti-H. pylori antibodies in serum are remarkable. This could be explained by an early 
detection of H. pylori presence after primary infection, when the antibody response has not 
started yet. Next, the possibility that H. pylori could colonize the oral cavity and the 
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oropharynx without inducing the host immune response must be considered. Another 
possible explanation is the presence of H. pylori coccoid forms. These are viable form of 
bacteria that can not be cultivated by conventional microbiological techniques and are 
characterized by a reduced virulence. 
The question of transmission of H. pylori has not been satisfactorily resolved yet. If we 
consider the oral-oral or faecal-oral route as a way of transmission, we can assume finding 
of the same H. pylori strains in the oropharynx and stomach in the same individual. The 
findings of different genotypes in both locations still lack an accurate explanation. 
Inoculation of mixtures of H. pylori strains and consequently their different settlements in 
the different areas according to sensitivity of the strains could be one of the possible 
explanations. It can be assumed that the area of the oropharynx is less favourable for H. 
pylori, and can only be colonized by more resistant strains. One of the negative factors for 
growth and reproduction of H. pylori is the presence of other bacterial strains that were able 
to stop the growth of H. pylori during in-vitro experiments. A variety of bacterial 
colonization in the oral cavity and oropharynx can be assumed. 
Epidemiological data on the prevalence of H. pylori infection published in the literature are 
often based on serological detection of specific anti-H. pylori antibodies. The prevalence of 
infection is reported 40-80%. The presence of anti-H. pylori antibodies was given in relation 
only to gastric infection. The newly obtained data prove the possibility of the presence of H. 
pylori infection in other locations independently to the gastric infection. This should be 
considered in future epidemiological studies. Not only antibodies should be evaluated but 
also identification of the exact location of the infection must be done.  
In the future it would be appropriate to focus attention on local effects of H. pylori in 
oropharyngeal lymphoid tissue. Changes in the expression of some cytokines caused by H. 
pylori, which were described in the gastric mucosa, can be expected in the oropharyngeal 
tissue. Another study focused on oropharyngeal H. pylori genotyping should be done. In 
case that high virulent H. pylori strains can survive in oropharyngeal tissue, translocation of 
toxins into the oropharyngeal mucosa cells with subsequent cytokine response can be 
expected. Nevertheless this assumption has not been confirmed nor refuted yet.  
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